RSU award lifts Takeda (NYSE: TAK) president’s holdings to 297,363 ADS

Rhea-AI Filing Summary

Platford Giles Richard reported acquisition or exercise transactions in this Form 4 filing.

Takeda Pharmaceutical executive Giles Richard Platford, President IBU, received a grant of 72,124 American Depositary Shares on April 27, 2026 as a performance-based restricted stock unit (RSU) award at no cash cost to him.

The award was determined by the Compensation Committee using performance metrics including core revenue, core operating profit and important R&D milestones from an RSU grant originally made on July 1, 2023. Following this award, Platford directly holds 297,363 American Depositary Shares, including 166,744 RSUs scheduled to vest on July 1, 2026 (116,762 shares), July 1, 2027 (32,396 shares) and July 1, 2028 (17,586 shares).

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Platford Giles Richard

Role President, IBU

Type	Security	Shares	Price	Value
Grant/Award	American Depositary Shares	72,124	$0.00	--

Holdings After Transaction: American Depositary Shares — 297,363 shares (Direct, null)

Footnotes (1)

1. On July 1, 2023, the reporting person was granted an award of restricted stock units (RSUs), which vest in the form of American Depositary Shares based upon the achievement of the specified performance metrics, including core revenue, core operating profit, and important R&D milestones. On April 27, 2026, the Compensation Committee of the Board of Directors determined the number of RSUs to be awarded based on these performance metrics, which amount is reported above. Includes 166,744 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one American Depositary Share. The RSUs vest on the following schedule: July 1, 2026 (116,762 shares), July 1, 2027 (32,396 shares) and July 1, 2028 (17,586 shares).

Key Figures

RSU award: 72,124 American Depositary Shares Total holdings after transaction: 297,363 American Depositary Shares Unvested RSUs: 166,744 RSUs +4 more

7 metrics

RSU award 72,124 American Depositary Shares Grant/award acquisition on April 27, 2026

Total holdings after transaction 297,363 American Depositary Shares Direct ownership following April 27, 2026 award

Unvested RSUs 166,744 RSUs Contingent right to receive ADS as of April 27, 2026

RSUs vesting July 1, 2026 116,762 shares First vesting tranche

RSUs vesting July 1, 2027 32,396 shares Second vesting tranche

RSUs vesting July 1, 2028 17,586 shares Third vesting tranche

Grant price per share $0.0000 per share Non-cash grant, compensation-related

Key Terms

restricted stock units (RSUs), American Depositary Shares, core operating profit, important R&D milestones, +1 more

5 terms

restricted stock units (RSUs) financial

"the reporting person was granted an award of restricted stock units (RSUs), which vest in the form of American Depositary Shares"

Restricted stock units (RSUs) are a type of company promise to give employees shares of stock in the future, usually after certain conditions like working for a set time. They are like a gift promised today that you receive later, which can become valuable if the company's stock price goes up. RSUs matter because they are a way companies reward employees and can be a significant part of compensation.

American Depositary Shares financial

"Each RSU represents a contingent right to receive one American Depositary Share."

American depositary shares (ADSs) are a way for investors in the United States to buy shares of foreign companies without dealing with international markets directly. They represent ownership in a foreign company's stock and are traded on U.S. stock exchanges, making it easier for American investors to buy, sell, and own parts of companies from around the world.

core operating profit financial

"based upon the achievement of the specified performance metrics, including core revenue, core operating profit, and important R&D milestones."

Core operating profit is the company's profit from its normal day-to-day business activities after removing one-time items, unusual gains or losses, and financing or tax effects. Investors use it like a household budget that strips out unexpected windfalls or repairs: it shows the steady earnings power of the business and helps compare performance across periods or with peers without distortion from rare or non‑operational events.

important R&D milestones financial

"including core revenue, core operating profit, and important R&D milestones."

Compensation Committee financial

"the Compensation Committee of the Board of Directors determined the number of RSUs to be awarded"

A compensation committee is a group within a company's leadership responsible for setting and reviewing how much top executives and employees are paid, including salaries, bonuses, and benefits. It matters to investors because fair and effective pay decisions can influence a company's performance, leadership motivation, and overall governance, helping ensure that the company’s management is aligned with shareholders’ interests.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Platford Giles Richard

(Last) (First) (Middle)

650 E. KENDALL STREET

(Street)

CAMBRIDGE MASSACHUSETTS 02142

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
TAKEDA PHARMACEUTICAL CO LTD [ TAK ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President, IBU

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/27/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
American Depositary Shares	04/27/2026		A(1)		72,124	A	$0	297,363(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. On July 1, 2023, the reporting person was granted an award of restricted stock units (RSUs), which vest in the form of American Depositary Shares based upon the achievement of the specified performance metrics, including core revenue, core operating profit, and important R&D milestones. On April 27, 2026, the Compensation Committee of the Board of Directors determined the number of RSUs to be awarded based on these performance metrics, which amount is reported above.

2. Includes 166,744 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one American Depositary Share. The RSUs vest on the following schedule: July 1, 2026 (116,762 shares), July 1, 2027 (32,396 shares) and July 1, 2028 (17,586 shares).

Remarks:

	/s/ Max Heuer, by power of attorney, for Giles Platford	04/27/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did Takeda (TAK) executive Giles Platford report in this Form 4?

Giles Richard Platford reported receiving 72,124 American Depositary Shares as a performance-based restricted stock unit award. The grant reflects compensation for achieving targets tied to core revenue, core operating profit and important R&D milestones from an RSU award originally granted on July 1, 2023.

How many Takeda (TAK) shares does Giles Platford hold after this RSU award?

After the award, Giles Richard Platford directly holds 297,363 American Depositary Shares of Takeda. This total includes 166,744 restricted stock units, which represent contingent rights to receive the same number of American Depositary Shares as they vest over future years.

What performance metrics determined Giles Platford’s Takeda (TAK) RSU award?

The number of RSUs awarded to Giles Richard Platford was based on specified performance metrics: core revenue, core operating profit and important R&D milestones. On April 27, 2026, Takeda’s Compensation Committee determined the final RSU amount using these metrics from the July 1, 2023 grant.

How and when do Giles Platford’s Takeda (TAK) RSUs vest?

Giles Richard Platford’s 166,744 restricted stock units vest in American Depositary Shares on a set schedule. The RSUs vest on July 1, 2026 (116,762 shares), July 1, 2027 (32,396 shares) and July 1, 2028 (17,586 shares), assuming continued satisfaction of vesting conditions.

Did Giles Platford buy Takeda (TAK) shares on the open market?

No, the Form 4 shows a grant or award acquisition, not an open-market purchase. Platford received 72,124 American Depositary Shares at a price of $0.0000 per share as compensation through restricted stock units, rather than by paying cash in a market transaction.